1,264 Shares in Waters Corporation $WAT Acquired by Canvas Wealth Advisors LLC

Canvas Wealth Advisors LLC bought a new stake in shares of Waters Corporation (NYSE:WAT) in the 2nd quarter, Holdings Channel reports. The institutional investor bought 1,264 shares of the medical instruments supplier’s stock, valued at approximately $441,000.

Several other institutional investors and hedge funds also recently made changes to their positions in WAT. OVERSEA CHINESE BANKING Corp Ltd raised its position in shares of Waters by 676.8% during the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 705,733 shares of the medical instruments supplier’s stock valued at $260,112,000 after acquiring an additional 614,877 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Waters by 15.7% during the 1st quarter. Alliancebernstein L.P. now owns 3,070,671 shares of the medical instruments supplier’s stock valued at $1,131,757,000 after acquiring an additional 416,669 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Waters by 93.3% during the 1st quarter. Wellington Management Group LLP now owns 572,823 shares of the medical instruments supplier’s stock valued at $211,125,000 after acquiring an additional 276,433 shares during the last quarter. Nuveen LLC bought a new stake in shares of Waters during the 1st quarter valued at $94,028,000. Finally, Vanguard Group Inc. raised its position in shares of Waters by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 7,272,252 shares of the medical instruments supplier’s stock valued at $2,680,334,000 after acquiring an additional 173,584 shares during the last quarter. Institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on WAT. Wall Street Zen cut shares of Waters from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. UBS Group reissued a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Bank of America boosted their price target on shares of Waters from $370.00 to $375.00 and gave the company a “neutral” rating in a report on Thursday, June 26th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Waters and gave the company a “hold” rating in a report on Tuesday, August 5th. Finally, Robert W. Baird decreased their price target on shares of Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a report on Wednesday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, Waters currently has an average rating of “Moderate Buy” and a consensus target price of $376.80.

Waters Price Performance

Shares of NYSE WAT opened at $335.58 on Monday. The firm has a market cap of $19.97 billion, a PE ratio of 30.26, a PEG ratio of 3.12 and a beta of 1.04. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56. The company has a fifty day moving average price of $305.36 and a 200 day moving average price of $322.73.

Waters (NYSE:WAT) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The firm had revenue of $608.55 million during the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. Research analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.